- Recent Funding
- Investors
- Elevage Medical Technologies
Elevage Medical Technologies portfolio
Elevage Medical Technologies has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Nervonik's $52.5M Series B+ round in April 2026, alongside Amzak Health Investors, Foothill Ventures, Shangbay Capital and 2 others. That company is in Health and bio.
What Elevage Medical Technologies invests in
- Health and bio · 1 · 100%
- Manufacturing and industrial · 1 · 100%
How Elevage Medical Technologies invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $52.5M |
Elevage Medical Technologies portfolio companies
| Company | Round with Elevage Medical Technologies | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $52.5M | $65.5M | Apr 27, 2026 Series B+ |
Most frequent co-investors
LLumira Ventures1 shared round · last Apr 27, 2026
UU.S. Venture Partners1 shared round · last Apr 27, 2026
SShangbay Capital1 shared round · last Apr 27, 2026
FFoothill Ventures1 shared round · last Apr 27, 2026
AAmzak Health Investors1 shared round · last Apr 27, 2026
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Elevage Medical Technologies. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Elevage Medical Technologies, which is a subset of its real portfolio. API: /api/v1/investors/elevage-medical-technologies (get a free API key). More: the most active VC firms and new venture capital funds.